Impact of Bean Polyphenols and Phytic Acid on Iron Absorption
Study Details
Study Description
Brief Summary
Recently isolated low PA varieties (lpa) in wheat, rice, maize, barley and beans might have the potential to alleviate iron bioavailability problems associated with PA. These plants have normal phosphate levels, but reduced PA phosphate due to various modifications of the biosynthetic pathway of PA. So far lpa crops are in an early stage of development, most of them exhibiting reduced yield and seed germination. However, the lpa bean isolated by Campion and co-workers 2009 by chemical mutagenesis exhibited only 10 % of the native bean PA concentration without any defects in terms of growth and yield.
Crossing the lpa variety with bean varieties low in PP and high in iron might lead to the development of a variety which has the potential to improve the iron status of bean consuming populations.
The following study will evaluate the relative impact of PA and PP on iron absorption from beans by comparing iron absorption from four different bean varieties. Iron absorption from a bean with normal PA concentration and high PP concentration will be compared to iron absorption from a bean with normal PA and low PP concentration as well as to two lpa varieties, one with high and one with low PP concentration.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: lpa with high polyphenol
|
Other: 586/8x87 brown
2 x 50 g
|
Experimental: lpa with low polyphenol
|
Other: 586/8x87 white
2 x 50 g
|
Experimental: control bean with low polyphenol
|
Other: 586/8
2 x 50 g
|
Experimental: control bean with high polyphenol
|
Other: BAT 881
2 x 50 g
|
Outcome Measures
Primary Outcome Measures
- Shift in iron isotopic composition in blood after consumption of different bean varieties [1 month]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Non-pregnant, non-lactating women
-
Between 18 and 40 years
-
Below 65kg
Exclusion Criteria:
-
Metabolic, chronic and gastro-intestinal disease
-
Long-term medication
-
Blood donation within 6 month before the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ETH | Zurich | Switzerland | 8092 |
Sponsors and Collaborators
- Swiss Federal Institute of Technology
Investigators
- Principal Investigator: Richard Hurrell, Prof. Dr., ETH Zürich
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- lpa_586/8X87